Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-26

Clinical Trial Update: Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the effect of PF-04360365 on amyloid-beta in patients with Alzheimer's disease and in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-04360365

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED